Ameriprise Financial Inc Bio Rad Laboratories, Inc. Transaction History

Ameriprise Financial Inc

  • $364 Billion
  • Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 16,701 shares of BIO stock, worth $5.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,701
Previous 11,833 41.14%
Holding current value
$5.49 Million
Previous $4.09 Million 11.46%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$268.26 - $339.48 $1.31 Million - $1.65 Million
4,868 Added 41.14%
16,701 $4.56 Million
Q1 2024

May 15, 2024
BUY
$304.11 - $351.99 $13,076 - $15,135
43 Added 0.36%
11,833 $4.09 Million
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $109,902 - $148,936
-408 Reduced 3.34%
11,790 $3.81 Million
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $34,324 - $41,417
-98 Reduced 0.8%
12,198 $4.37 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $826,108 - $1.12 Million
-2,298 Reduced 15.75%
12,296 $4.66 Million
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $932,841 - $1.12 Million
2,228 Added 18.02%
14,594 $6.99 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $305,284 - $395,816
868 Added 7.55%
12,366 $5.2 Million
Q3 2022

Nov 14, 2022
SELL
$412.59 - $563.26 $245,078 - $334,576
-594 Reduced 4.91%
11,498 $4.8 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $4.1 Million - $5.28 Million
-8,839 Reduced 42.23%
12,092 $5.98 Million
Q1 2022

May 16, 2022
SELL
$524.57 - $735.42 $25.1 Million - $35.3 Million
-47,935 Reduced 69.61%
20,931 $11.8 Million
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $481,302 - $539,587
679 Added 1.0%
68,866 $52 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $21.1 Million - $26.5 Million
-32,055 Reduced 31.98%
68,187 $51 Million
Q2 2021

Aug 16, 2021
BUY
$576.64 - $649.04 $5.05 Million - $5.69 Million
8,761 Added 9.58%
100,242 $64.6 Million
Q1 2021

May 17, 2021
SELL
$547.01 - $662.35 $40.9 Million - $49.5 Million
-74,716 Reduced 44.96%
91,481 $52.2 Million
Q4 2020

Feb 12, 2021
SELL
$510.68 - $643.45 $1.13 Million - $1.43 Million
-2,218 Reduced 1.32%
166,197 $96.9 Million
Q3 2020

Nov 16, 2020
SELL
$454.43 - $535.6 $7.95 Million - $9.37 Million
-17,496 Reduced 9.41%
168,415 $86.8 Million
Q2 2020

Aug 14, 2020
SELL
$334.87 - $493.06 $10.4 Million - $15.3 Million
-31,097 Reduced 14.33%
185,911 $83.9 Million
Q1 2020

May 15, 2020
BUY
$320.01 - $409.07 $48.4 Million - $61.9 Million
151,358 Added 230.55%
217,008 $76.1 Million
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $2.01 Million - $2.35 Million
6,286 Added 10.59%
65,650 $24.2 Million
Q3 2019

Nov 14, 2019
BUY
$304.55 - $345.24 $172,679 - $195,751
567 Added 0.96%
59,364 $19.8 Million
Q2 2019

Aug 14, 2019
SELL
$286.93 - $312.59 $473,434 - $515,773
-1,650 Reduced 2.73%
58,797 $18.4 Million
Q1 2019

May 15, 2019
SELL
$224.3 - $317.41 $266,692 - $377,400
-1,189 Reduced 1.93%
60,447 $18.5 Million
Q4 2018

Feb 14, 2019
SELL
$220.1 - $309.0 $845,624 - $1.19 Million
-3,842 Reduced 5.87%
61,636 $14.3 Million
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $423,216 - $477,157
-1,463 Reduced 2.19%
65,478 $20.5 Million
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $187,224 - $233,075
767 Added 1.16%
66,941 $19.3 Million
Q1 2018

May 15, 2018
BUY
$233.97 - $274.11 $100,841 - $118,141
431 Added 0.66%
66,174 $16.5 Million
Q4 2017

Feb 12, 2018
BUY
$216.94 - $271.3 $805,498 - $1.01 Million
3,713 Added 5.99%
65,743 $15.7 Million
Q3 2017

Nov 07, 2017
BUY
$212.27 - $242.28 $13.2 Million - $15 Million
62,030
62,030 $13.8 Million

Others Institutions Holding BIO

# of Institutions
459
Shares Held
19.6M
Call Options Held
23.2K
Put Options Held
37.4K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email